Abstract
Objectives: To determine which members are most affected by toxoplasmosis in patients seropositive for HIV / AIDS, demonstrate the prevalence of toxoplasmosis in these patients, identify the most used prophylaxis for toxoplasmosis. Methods: Study descriptive, exploratory and quantitative approach. 537 records of cases of HIV / AIDS were analyzed, according to the inclusion and exclusion criteria, where data were collected from 72 medical records of patients with HIV / AIDS and had contact with the protozoan Toxoplasma gondii. Results: The sample consisted of 537 medical records, which were selected 72 who had positive serology for toxoplasmosis IgG. 34 were male (47.2%) and 38 female (52.8%), age 20-30 is distributed 04 (5.60%), 31-40 25 (34.7%), 41-50 22 (30.6%) 51-60 15 (20.8%) 61-70 05 (6.9%) 81-90 01 (1.4%). it was the 72 records analyzed which showed serology anti-toxoplasmosis IgG 72 (100%) were reagent prophylaxis variable to neurotoxoplasmosis 68 (94.4%) did not use drugs, and 01 (1.4%) used clindamycin, pirimetamida and folinic acid, and 03 (4.2%) made use of sulfadiazine, pirimetamida and folinic acid in variable sequelae left by toxoplasmosis 68 (94.4%) were not informed, 01 (1.4%) sequelae in upper and lower left, 03 (4.2%) sequelae in the upper and lower right members. Conclusion: It was noted that most HIV / AIDS with coinfection who had contact with the protozoan were female, the co-infected by toxoplasmosis had treatment with clindamycin, pyrimethamine and acid folinic, and sulfadiazine, pyrimethamine and acid folinic, the consequences left by toxoplasmosis was partial loss of movement in the arms and legs.